21
Participants
Start Date
September 30, 2015
Primary Completion Date
March 31, 2016
Study Completion Date
October 31, 2016
Ceftolozane/Tazobactam
1 hour intravenous infusion
St. Christopher's Hospital for Children, Philadelphia
University of North Carolina Medical Center, Chapel Hill
Riley Hospital for Children at Indiana University Health, Indianapolis
Hartford Hospital, Hartford
Collaborators (1)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
INDUSTRY
Indiana University Health
OTHER
University of North Carolina
OTHER
St. Christopher's Hospital for Children
OTHER
Joseph L. Kuti, PharmD
OTHER